Literature DB >> 11568857

Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus.

C D Paddock1, S M Folk, G M Shore, L J Machado, M M Huycke, L N Slater, A M Liddell, R S Buller, G A Storch, T P Monson, D Rimland, J W Sumner, J Singleton, K C Bloch, Y W Tang, S M Standaert, J E Childs.   

Abstract

The clinical course and laboratory evaluation of 21 patients coinfected with human immunodeficiency virus (HIV) and Ehrlichia chaffeensis or Ehrlichia ewingii are reviewed and summarized, including 13 cases of ehrlichiosis caused by E. chaffeensis, 4 caused by E. ewingii, and 4 caused by either E. chaffeensis or E. ewingii. Twenty patients were male, and the median CD4(+) T lymphocyte count was 137 cells/microL. Exposures to infecting ticks were linked to recreational pursuits, occupations, and peridomestic activities. For 8 patients, a diagnosis of ehrlichiosis was not considered until > or =4 days after presentation. Severe manifestations occurred more frequently among patients infected with E. chaffeensis than they did among patients infected with E. ewingii, and all 6 deaths were caused by E. chaffeensis. Ehrlichiosis may be a life-threatening illness in HIV-infected persons, and the influence of multiple factors, including recent changes in the epidemiology and medical management of HIV infection, may increase the frequency with which ehrlichioses occur in this patient cohort.

Entities:  

Mesh:

Year:  2001        PMID: 11568857     DOI: 10.1086/323981

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  33 in total

1.  Ehrlichia chaffeensis induces monocyte inflammatory responses through MyD88, ERK, and NF-κB but not through TRIF, interleukin-1 receptor 1 (IL-1R1)/IL-18R1, or toll-like receptors.

Authors:  Koshiro Miura; Junji Matsuo; M Akhlakur Rahman; Yumi Kumagai; Xin Li; Yasuko Rikihisa
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

Review 2.  Molecular and cellular pathobiology of Ehrlichia infection: targets for new therapeutics and immunomodulation strategies.

Authors:  Jere W McBride; David H Walker
Journal:  Expert Rev Mol Med       Date:  2011-01-31       Impact factor: 5.600

3.  Renal, hepatic, and marrow dysfunction in a patient with chronic renal insufficiency.

Authors:  Rebecca C Brady; John J Bissler
Journal:  Pediatr Nephrol       Date:  2003-02-12       Impact factor: 3.714

4.  Detection and identification of Ehrlichia species in blood by use of PCR and electrospray ionization mass spectrometry.

Authors:  Mark W Eshoo; Chris D Crowder; Haijing Li; Heather E Matthews; Shufang Meng; Susan E Sefers; Rangarajan Sampath; Charles W Stratton; Lawrence B Blyn; David J Ecker; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

5.  First reported case of Ehrlichia ewingii involving human bone marrow.

Authors:  M Brandon Allen; Bobbi S Pritt; Lynne M Sloan; Christopher D Paddock; Chaitanya K Musham; Jeanette M Ramos; Neslihan Cetin; Eric R Rosenbaum
Journal:  J Clin Microbiol       Date:  2014-09-03       Impact factor: 5.948

6.  Immunization with Ehrlichia P28 outer membrane proteins confers protection in a mouse model of ehrlichiosis.

Authors:  Patricia A Crocquet-Valdes; Nagaraja R Thirumalapura; Nahed Ismail; Xuejie Yu; Tais B Saito; Heather L Stevenson; Colette A Pietzsch; Sunil Thomas; David H Walker
Journal:  Clin Vaccine Immunol       Date:  2011-10-26

Review 7.  Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.

Authors:  Kathleen E Sullivan; Hamid Bassiri; Ahmed A Bousfiha; Beatriz T Costa-Carvalho; Alexandra F Freeman; David Hagin; Yu L Lau; Michail S Lionakis; Ileana Moreira; Jorge A Pinto; M Isabel de Moraes-Pinto; Amit Rawat; Shereen M Reda; Saul Oswaldo Lugo Reyes; Mikko Seppänen; Mimi L K Tang
Journal:  J Clin Immunol       Date:  2017-08-07       Impact factor: 8.317

8.  Histologic, serologic, and molecular analysis of persistent ehrlichiosis in a murine model.

Authors:  Juan P Olano; Gary Wen; Hui-Min Feng; Jere W McBride; David H Walker
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

Review 9.  Severe Ehrlichia chaffeensis infection in a lung transplant recipient: a review of ehrlichiosis in the immunocompromised patient.

Authors:  Nasia Safdar; Robert B Love; Dennis G Maki
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

10.  Ehrlichia ewingii infection in white-tailed deer (Odocoileus virginianus).

Authors:  Michael J Yabsley; Andrea S Varela; Cynthia M Tate; Vivien G Dugan; David E Stallknecht; Susan E Little; William R Davidson
Journal:  Emerg Infect Dis       Date:  2002-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.